Sentinus LLC’s Northwest Biotherapeutics NWBO Stock Holding History
Bought
Maintained
Sold
Other funds holding NWBO
Sentinus LLC's NWBO Position: Q1 2025 in Review
Sentinus LLC sold out of Northwest Biotherapeutics (NWBO) in Q1 2025, closing a stake of 12,925 shares — an estimated $3.55K sold.
Sentinus LLC first reported a position in NWBO in Q3 2022 and held it in 6 quarters. The position peaked at $1.45M in Q4 2022. 8 funds tracked by Wall St. Rank hold NWBO as of Q1 2025.
- Sentinus LLC reported no remaining Northwest Biotherapeutics position as of Q1 2025 after selling out during the quarter.
- Sentinus LLC sold 12,925 Northwest Biotherapeutics shares in Q1 2025, an estimated $3.55K.
- Sentinus LLC first reported a position in Northwest Biotherapeutics in Q3 2022 and held it in 6 quarters.
- Sentinus LLC's Northwest Biotherapeutics position peaked at $1.45M in Q4 2022.
- 8 funds tracked by Wall St. Rank held Northwest Biotherapeutics as of Q1 2025.
Based on Sentinus LLC's 13F filing for Q1 2025, filed 15 May 2025.